{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T04:17:56Z","timestamp":1784780276123,"version":"3.55.0"},"reference-count":22,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,5,9]],"date-time":"2023-05-09T00:00:00Z","timestamp":1683590400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontierspartnerships.org"],"crossmark-restriction":true},"short-container-title":["Transpl Int"],"abstract":"<jats:p>Early-on post kidney transplantation, there is a high risk of graft rejection and opportunistic viral infections. A low tacrolimus concentration\/dose (C\/D) ratio as a surrogate marker of fast tacrolimus metabolism has been established for risk stratification 3\u00a0months post-transplantation (M3). However, many adverse events occurring earlier might be missed, and stratification at 1\u00a0month post-transplantation (M1) has not been investigated. We retrospectively analyzed case data from 589 patients who had undergone kidney transplantation between 2011 and 2021\u00a0at three German transplant centers. Tacrolimus metabolism was estimated by use of the C\/D ratio at M1, M3, M6, and M12. C\/D ratios increased substantially during the year, particularly between M1 and M3. Many viral infections and most graft rejections occurred before M3. Neither at M1 nor at M3 was a low C\/D ratio associated with susceptibility to BKV viremia or BKV nephritis. A low C\/D ratio at M1 could not predict acute graft rejections or impaired kidney function, whereas at M3 it was significantly associated with subsequent rejections and impairment of kidney function. In summary, most rejections occur before M3, but a low C\/D ratio at M1 does not identify patients at risk, limiting the predictive utility of this stratification approach.<\/jats:p>","DOI":"10.3389\/ti.2023.11027","type":"journal-article","created":{"date-parts":[[2023,5,9]],"date-time":"2023-05-09T04:11:23Z","timestamp":1683605483000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":7,"title":["The Tacrolimus Concentration\/Dose Ratio Does Not Predict Early Complications After Kidney Transplantation"],"prefix":"10.3389","volume":"36","author":[{"given":"Friedrich Alexander","family":"von Samson-Himmelstjerna","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maja Lucia","family":"Messtorff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nassim","family":"Kakavand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ute","family":"Eisenberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"Korth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich","family":"Lange","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benedikt","family":"Kolbrink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leon","family":"Aldag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Schulze Dieckhoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thorsten","family":"Feldkamp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich","family":"Kunzendorf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Harth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Schulte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,5,9]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.1111\/j.1600-6143.2011.03686.x","article-title":"Systematic Review: Kidney Transplantation Compared with Dialysis in Clinically Relevant Outcomes","volume":"11","author":"Tonelli","year":"2011","journal-title":"Am J Transpl"},{"key":"B2","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1111\/j.1600-6143.2011.03840.x","article-title":"Understanding the Causes of Kidney Transplant Failure: the Dominant Role of Antibody-Mediated Rejection and Nonadherence","volume":"12","author":"Sellar\u00e9s","year":"2012","journal-title":"Am J Transpl"},{"key":"B3","doi-asserted-by":"publisher","first-page":"2562","DOI":"10.1056\/NEJMoa067411","article-title":"Reduced Exposure to Calcineurin Inhibitors in Renal Transplantation","volume":"357","author":"Ekberg","year":"2007","journal-title":"N Engl J Med"},{"key":"B4","doi-asserted-by":"publisher","first-page":"328","DOI":"10.2133\/dmpk.22.328","article-title":"Metabolism of Tacrolimus (FK506) and Recent Topics in Clinical Pharmacokinetics","volume":"22","author":"Iwasaki","year":"2007","journal-title":"Drug Metab Pharmacokinet"},{"key":"B5","doi-asserted-by":"publisher","first-page":"5785","DOI":"10.4049\/jimmunol.1390055","article-title":"Calcineurin Inhibitors: 40 Years Later, Can\u2019t Live without","volume":"191","author":"Azzi","year":"2013","journal-title":"J Immunol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1016\/j.transproceed.2011.11.053","article-title":"Cytomegalovirus Disease in Kidney Transplant Recipients: Incidence, Clinical Profile, and Risk Factors","volume":"44","author":"Cordero","year":"2012","journal-title":"Transpl Proc"},{"key":"B7","doi-asserted-by":"publisher","first-page":"S68","DOI":"10.2215\/cjn.02770707","article-title":"BK Virus Nephritis after Renal Transplantation","volume":"3","author":"Dall","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1038\/s41579-021-00582-z","article-title":"Pathogenesis of Human Cytomegalovirus in the Immunocompromised Host","volume":"19","author":"Griffiths","year":"2021","journal-title":"Nat Rev Microbiol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"e111128","DOI":"10.1371\/journal.pone.0111128","article-title":"The Tacrolimus Metabolism Rate Influences Renal Function after Kidney Transplantation","volume":"9","author":"Th\u00f6lking","year":"2014","journal-title":"PLoS One"},{"key":"B10","doi-asserted-by":"publisher","first-page":"32273","DOI":"10.1038\/srep32273","article-title":"Influence of Tacrolimus Metabolism Rate on BKV Infection after Kidney Transplantation","volume":"6","author":"Th\u00f6lking","year":"2016","journal-title":"Sci Rep"},{"key":"B11","doi-asserted-by":"publisher","first-page":"15606","DOI":"10.1038\/s41598-021-95201-5","article-title":"Increased Renal Function Decline in Fast Metabolizers Using Extended-Release Tacrolimus after Kidney Transplantation","volume":"11","author":"Th\u00f6lking","year":"2021","journal-title":"Sci Rep"},{"key":"B12","doi-asserted-by":"publisher","first-page":"587","DOI":"10.3390\/jcm8050587","article-title":"Fast Tac Metabolizers at Risk \u207b it Is Time for a C\/D Ratio Calculation","volume":"8","author":"Sch\u00fctte-N\u00fctgen","year":"2019","journal-title":"J Clin Med"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1097\/tp.0000000000002920","article-title":"The TOMATO Study (Tacrolimus Metabolization in Kidney Transplantation): Impact of the Concentration-Dose Ratio on Death-Censored Graft Survival","volume":"104","author":"Jouve","year":"2020","journal-title":"Transplantation"},{"key":"B14","doi-asserted-by":"publisher","first-page":"2318","DOI":"10.1111\/ajt.15898","article-title":"The Banff 2019 Kidney Meeting Report (I): Updates on and Clarification of Criteria for T Cell\u2013 and Antibody-Mediated Rejection","volume":"20","author":"Loupy","year":"2020","journal-title":"Am J Transpl"},{"key":"B15","doi-asserted-by":"publisher","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A New Equation to Estimate Glomerular Filtration Rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann Intern Med"},{"key":"B16","doi-asserted-by":"publisher","first-page":"2409","DOI":"10.1093\/ndt\/gfg381","article-title":"Pharmacokinetic Interaction between Corticosteroids and Tacrolimus after Renal Transplantation","volume":"18","author":"Anglicheau","year":"2003","journal-title":"Nephrol Dial Transpl"},{"key":"B17","doi-asserted-by":"publisher","first-page":"e273","DOI":"10.1097\/tp.0000000000001796","article-title":"High Tacrolimus Clearance Is a Risk Factor for Acute Rejection in the Early Phase after Renal Transplantation","volume":"101","author":"Egeland","year":"2017","journal-title":"Transplantation"},{"key":"B18","doi-asserted-by":"publisher","first-page":"e923278","DOI":"10.12659\/aot.923278","article-title":"Effect of Concentration\/Dose Ratio in De Novo Kidney Transplant Recipients Receiving LCP-Tacrolimus or Immediate-Release Tacrolimus: Post Hoc Analysis of a Phase 3 Clinical Trial","volume":"25","author":"Suwelack","year":"2020","journal-title":"Ann Transpl"},{"key":"B19","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1111\/j.1600-6143.2010.03016.x","article-title":"A Phase III Study of Belatacept versus Cyclosporine in Kidney Transplants from Extended Criteria Donors (BENEFIT-EXT Study)","volume":"10","author":"Durrbach","year":"2010","journal-title":"Am J Transpl"},{"key":"B20","doi-asserted-by":"publisher","first-page":"3192","DOI":"10.1111\/ajt.13830","article-title":"Long-Term Outcomes in Belatacept- versus Cyclosporine-Treated Recipients of Extended Criteria Donor Kidneys: Final Results from BENEFIT-EXT, a Phase III Randomized Study","volume":"16","author":"Durrbach","year":"2016","journal-title":"Am J Transpl"},{"key":"B21","doi-asserted-by":"publisher","first-page":"2582","DOI":"10.1097\/tp.0000000000001589","article-title":"Belatacept Compared with Tacrolimus for Kidney Transplantation: A Propensity Score Matched Cohort Study","volume":"101","author":"Cohen","year":"2017","journal-title":"Transplantation"},{"key":"B22","doi-asserted-by":"publisher","first-page":"2571","DOI":"10.1097\/tp.0000000000001755","article-title":"A Randomized Controlled Clinical Trial Comparing Belatacept with Tacrolimus after De Novo Kidney Transplantation","volume":"101","author":"de Graav","year":"2017","journal-title":"Transplantation"}],"container-title":["Transplant International"],"original-title":[],"link":[{"URL":"https:\/\/www.frontierspartnerships.org\/articles\/10.3389\/ti.2023.11027\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,9]],"date-time":"2023-05-09T04:11:32Z","timestamp":1683605492000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontierspartnerships.org\/articles\/10.3389\/ti.2023.11027\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,9]]},"references-count":22,"alternative-id":["10.3389\/ti.2023.11027"],"URL":"https:\/\/doi.org\/10.3389\/ti.2023.11027","relation":{},"ISSN":["1432-2277"],"issn-type":[{"value":"1432-2277","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,9]]},"article-number":"11027"}}